Special Bulletin
AHA Comments to FDA Re: Market Claims in Direct-to-Consumer Prescription Drug Print Ads
AHA comments on the FDA study on market claims in direct-to-consumer prescription drug print advertising.
Key Resources
Related Resources
Letter/Comment